Yes. Efti has already demonstrated that it can greatly increase the number of patients that will benefit from Keytruda in head and neck and small cell lung cancer with a fraction of the side effects of Keytruda and chemo.
Which means BIG dollars.
It is no accident that the FDA have fast tracked the head and neck trial and the lung cancer trial has expanded dramatically and recruited ahead of schedule. Tacti-003 has started enrolling and how quickly it recruits will give us a very good indication of our status. This is a company making trial and will be exciting to follow.
Can’t understand why the share price is slipping back but that’s how it goes. Should be a very interesting 2022.
- Forums
- ASX - By Stock
- IMM
- Ann: Phase II TACTI-002 trial recruitment successfully completed
Ann: Phase II TACTI-002 trial recruitment successfully completed, page-6
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
29.0¢ | 29.5¢ | 29.0¢ | $82.00K | 280.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
33 | 348533 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 174205 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 262330 | 0.290 |
23 | 353540 | 0.285 |
22 | 564331 | 0.280 |
9 | 250994 | 0.275 |
10 | 248779 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 174205 | 22 |
0.300 | 644667 | 7 |
0.305 | 209525 | 12 |
0.310 | 528209 | 7 |
0.315 | 178652 | 9 |
Last trade - 11.36am 11/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online